Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Zentalis Pharmaceuticals, Inc. (ZNTL) had Weighted-Average Shares Outstanding (Diluted) of 71.68M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-48.28M |
|
-- |
|
-- |
|
$45.62M |
|
$-45.62M |
|
$-2.66M |
|
$-48.28M |
|
$-48.28M |
|
$-48.28M |
|
$-48.28M |
|
$-48.28M |
|
$-48.28M |
|
$-45.62M |
|
$-46.40M |
|
71.68M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
71.68M |
$-0.67 |
|
$-0.67 |
|
| Balance Sheet Financials | |
$342.88M |
|
$3.25M |
|
$41.14M |
|
$384.02M |
|
$49.43M |
|
-- |
|
$39.21M |
|
$88.64M |
|
$295.38M |
|
$295.38M |
|
$295.38M |
|
71.95M |
|
| Cash Flow Statement Financials | |
$-32.64M |
|
$40.48M |
|
$0.19M |
|
$36.53M |
|
$44.56M |
|
$8.03M |
|
$6.49M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.94 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-32.63M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-16.34% |
|
-16.34% |
|
-12.57% |
|
-16.34% |
|
$4.11 |
|
$-0.46 |
|
$-0.46 |
|